Human papillomavirus vaccine initiation among 9–13-year-olds in the United States

The quadrivalent and 9-valent human papillomavirus (HPV) vaccines are licensed for administration among 9–26-year-old males and females, with routine vaccination recommended for 11–12-year-olds. Despite the availability of the vaccine at younger ages, few studies have explored vaccine uptake prior t...

Descripción completa

Detalles Bibliográficos
Autores principales: Donahue, Kelly L., Hendrix, Kristin S., Sturm, Lynne A., Zimet, Gregory D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652326/
https://www.ncbi.nlm.nih.gov/pubmed/26594616
http://dx.doi.org/10.1016/j.pmedr.2015.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652326/
https://www.ncbi.nlm.nih.gov/pubmed/26594616
http://dx.doi.org/10.1016/j.pmedr.2015.10.003

Ejemplares similares